Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation

摘要

BackgroundDevelopment of primary lung cancer in donor lung post-lung transplantation is very rare, with few described cases. The safety of stereotactic ablative radiotherapy (SABR) for early-stage lung cancer arising from donor lung is unclear.